肝硬変患者におけるトランジジュキュラ内側移植システムシャント後の肝臓脳病の危険因子: 総合的なミニレビュー
Jing-Qiu Zhang1, De-Lei Cheng2, Chun-Ze Zhou3
1Graduate School, Bengbu Medical University, Bengbu 233030, Anhui Province, China.
World journal of hepatology
|September 3, 2025
まとめ
肝硬変患者の肝臓内シャント (TIPS) は肝臓脳症 (HE) を引き起こす可能性があります. このレビューでは,患者の選択を改善し,HEの発生率を減らすためにリスク要因を分析しています.
科学分野:
- ヘパトロジー
- 介入放射線学
- 神経学
背景:
- 肝硬変におけるポータル高血圧に対する重要な介入である.
- 肝臓脳病 (HE) は TIPSの手術後の重大な合併症です.
- TIPS後のHEの病原性は多因性であり,寄与する要素のより深い理解を必要とします.
研究 の 目的:
- TIPS後の肝臓脳症に関連した危険因子を包括的に分析する.
- 手術手順のパラメータと代謝メカニズムを 多次元リスク評価に統合する.
- TIPS HE後の治療プロトコルと管理戦略の最適化のための洞察を提供すること.
主な方法:
- TIPS後の肝臓脳症に関する既存の文献のミニレビュー
- 手術と代謝の側面を含む,特定された危険因子の分析.
- 現在の理解と管理のギャップを特定するための情報の統合
主要な成果:
- 以前の研究では,TIPS後のHEに寄与するいくつかの要因が特定されました.
- プロセスと代謝因子の総合的な統合にはギャップがある.
- 効果的なリスクの分層化には多次元分析が必要である.
結論:
- TIPSの患者を慎重に選択することは,HEのリスクを軽減するために極めて重要です.
- 様々な要因を統合したさらなる研究は,TIPS後のHE発生率を減らすために不可欠です.
- 治療戦略を最適化することで TIPSを患っている 肝硬変患者の治療結果を改善できます
関連する概念動画
Esophageal Varices-II: Clinical Features and Management
135
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
135
Hepatic Portal System
2.1K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
2.1K
Hepatic Drug Excretion: Influencing Factors
214
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
214
Esophageal Varices-I: Introduction
332
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
332
Diseases of the Liver and Gallbladder
965
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
965
Hepatic Drug Clearance: Role of Transporters
100
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
100


